Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)
Clinical trial NCT05128643 · UNKNOWN
Trial details
- NCT number
- NCT05128643
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-17
- Primary completion
- 2022-04-12
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.